EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteolytic Activation of T Cell Engagers And Bispecific Proteins Using Modular Coiled-Coil Peptides

Basudeb Mondal iD, Yusef A Haikal, Gabriel A Kwong iD, John Blazeck iD

ACS Chemical Biology · 2026

DOI: 10.1021/acschembio.6c00688 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2026. Verfasst von Basudeb Mondal und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia30332, United States. Hauptthemen laut MEDLINE: T-Lymphocytes, Peptides, Antibodies, Bispecific. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Advanced Research Projects Agency for Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bispecific T cell engagers (BiTEs) are engineered immunotherapeutic molecules designed to direct the body’s immune system against malignant cells by physically connecting T cells to target cells, triggering cytotoxic responses. BiTEs have typically engaged T cells via αCD3 domains, such as OKT3 or UCHT1, which are linked to a second binding domain specific for a tumor-associated antigen. The risk of on-target off-tumor toxicity is a serious concern for BiTE immunotherapy due to the expression of tumor-associated antigen targets on healthy tissues. To address this concern, we have developed protease-responsive masked-BiTEs using OKT3 and UCHT1 mAb clones, that activate T cells only after exposure to tumor micro-environment-associated proteases and stimulate the T cell activation by their tumor-antigenic targets. Our protease-responsive masked BiTEs (mBiTEs) are comprised of αCD3 Fab proteins that are sterically prevented from binding CD3 via N’ terminal fusion of coiled-coil leucine zipper dimerization domains to each Fab chain, with further C’ terminal linkage to a tumoral-antigen targeting nanobody (either αPSMA or αHER2). The peptide linking each Fab chain and its coiled-coil masking zipper harbors a protease cleavable site, such that engagement of either recombinant or T cell displayed CD3 is significantly reduced until mBiTE protease activation. OKT3 and UCHT1-based masked T cell engagers (mTEs) showed ∼400-fold and ∼800-fold reduced affinity for CD3 protein compared to unmodified T cell engagers (TEs), with ∼222-fold and ∼457-fold restoration of binding upon proteolytic unmasking, respectively. mBiTEs did not activate Jurkat T cells while proteolytically unmasked proteins did, and mBiTEs harboring linkers cleavable by the cancer associated matric metalloprotease 2 (MMP2) enzyme enabled killing of PSMA + and HER2 + cancer cells in an MMP2-dependent manner in PBMC co-culture assays. The mBiTEs we describe here could be of broad utility towards helping constrain BiTE-mediated immune-activation to protease-high environments, such as the solid tumor microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-LymphocytesPeptidesAntibodies, BispecificHumansProteolysisCD3 ComplexLymphocyte Activation

Substanzen

PeptidesCD3 ComplexAntibodies, Bispecific

Autor:innen und Institutionen

  • School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia30332, United States.
  • William H. Coulter Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia30332, United States.
  • Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia30332, United States.
  • Cancer Technology Innovation Center, Georgia Institute of Technology, Atlanta, Georgia30332, United States.
  • Georgia Immunoengineering Consortium, Emory University and Georgia Institute of Technology, Atlanta, Georgia30332, United States.
  • Winship Cancer Institute of Emory University, Atlanta, Georgia30322, United States.

ORCID-Profile: Basudeb Mondal, Gabriel A Kwong, John Blazeck

Förderung

  • NCI NIH HHS
  • Advanced Research Projects Agency for Health
  • National Cancer Institute

Zitieren

APA

Mondal, B., Haikal, Y. A., Kwong, G. A., & Blazeck, J. (2026). Proteolytic Activation of T Cell Engagers And Bispecific Proteins Using Modular Coiled-Coil Peptides. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6c00688

Vancouver

Mondal B, Haikal YA, Kwong GA, Blazeck J. Proteolytic Activation of T Cell Engagers And Bispecific Proteins Using Modular Coiled-Coil Peptides. ACS Chemical Biology. 2026. doi:10.1021/acschembio.6c00688

BibTeX
@article{Mondal2026,
  author = {Mondal, Basudeb and Haikal, Yusef A and Kwong, Gabriel A and Blazeck, John},
  title = {Proteolytic Activation of T Cell Engagers And Bispecific Proteins Using Modular Coiled-Coil Peptides},
  journal = {ACS Chemical Biology},
  year = {2026},
  doi = {10.1021/acschembio.6c00688}
}
Kostenlos starten →